Publications by authors named "Martin Horack"

Claim this Profile
C
Cross-sectional evaluation of patients with refractory or unexplained chronic cough by office-based pulmonologists in Germany.
Peter Kardos, Heinrich Worth, Ulrich Koehler, Martin Horack, Barbara Karmann

Front Med (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care : Results of the COVID-19 Registry RLP.
Anselm K Gitt, Martin Horack, Steffen Schneider, Uwe Zeymer, Ralf Zahn

Herz· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome.
Jean Ferrières, Dominik Lautsch, Peter Bramlage, Martin Horack, Carl A Baxter

Arch Cardiovasc Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II.
Wacin Buddhari, Preecha Uerojanaungkul, Charn Sriratanasathavorn, Apichard Sukonthasarn, Baishali Ambegaonkar, Martin Horack

Heart Lung Circ· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II ).
Michel P Hermans, Sofie Gevaert, Olivier Descamps, Luc Missault, Bernard Gillot, Martin Horack

Acta Clin Belg· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
Kian-Keong Poh, Chee Tang Chin, Khim Leng Tong, Julian Ko Beng Tan, Jee Seong Lim, Martin Horack

Singapore Med J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea.
Sang-Hak Lee, Woo-Hyuk Song, Myung Ho Jeong, Seung-Ho Hur, Dong Woon Jeon, Martin Horack

J Lipid Atheroscler· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II.
Evangelos Liberopoulos, Loukianos Rallidis, Filio Spanoudi, Elena Xixi, Anselm Gitt, Martin Horack

Arch Med Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab Emirates.
Wael Al Mahmeed, Sherif Bakir, Salem A Beshyah, Bassem Morcos, Sameh Wajih, Martin Horack

Heart Views· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do acute coronary events affect lipid management and cholesterol goal attainment in Germany? : Results from the Dyslipidemia International study II.
Anselm K Gitt, Johannes Rieber, Rainer Hambrecht, Johannes Brachmann, Kristof Graf, Martin Horack

Wien Klin Wochenschr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II.
Kian-Keong Poh, Baishali Ambegaonkar, Carl A Baxter, Philippe Brudi, Wacin Buddhari, Martin Horack

Eur J Prev Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
Jean Ferrieres, Gaetano Maria De Ferrari, Michel P Hermans, Moses Elisaf, Peter P Toth, Martin Horack

Eur J Prev Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS).
Jean Ferrières, Dominik Lautsch, Anselm K Gitt, Gaetano De Ferrari, Hermann Toplak, Martin Horack

Diabetes Obes Metab· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
Jean Ferrières, Dominik Lautsch, Baishali M Ambegaonkar, Gaetano M De Ferrari, Ami Vyas, Martin Horack

Int J Cardiol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
Gaetano M De Ferrari, Gian P Perna, Antonino Nicosia, Luigina Guasti, Gavino Casu, Martin Horack

J Cardiovasc Med (Hagerstown)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome.
Mohamed Sobhy, Adel El Etriby, Amany El Nashar, Sameh Wajih, Martin Horack

Egypt Heart J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
Bryan P Yan, Fu-Tien Chiang, Baishali Ambegaonkar, Philippe Brudi, Martin Horack

Int J Cardiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia.
Saud Al Sifri, Owayed Al Shammeri, Saleh Al Jaser, Abdullah Alkhenizan, Atif Bin Shafi Shafiurrehman, Martin Horack

Saudi Med J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world.
Anselm K Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M De Ferrari, Ami Vyas, Martin Horack

Data Brief· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does the TRS 2°P score relate to real-world patients?
Marc P Bonaca, Gaetano M De Ferrari, Dan Atar, Lori D Bash, Dominik Lautsch, Martin Horack

Eur Heart J Cardiovasc Pharmacother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world.
Anselm K Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M De Ferrari, Ami Vyas, Martin Horack

Data Brief· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
Anselm K Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M De Ferrari, Ami Vyas, Martin Horack

Atherosclerosis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
Anselm K Gitt, Dominik Lautsch, Jean Ferrieres, John Kastelein, Heinz Drexel, Martin Horack

Atherosclerosis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world.
Anselm K Gitt, Dominik Lautsch, Jean Ferrieres, John Kastelein, Heinz Drexel, Martin Horack

Data Brief· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in achievement of lipid targets in France: Comparison of data from coronary patients in the DYSIS and DYSIS II studies.
Jean Ferrières, Maja Velkovski Rouyer, Dominik Lautsch, Baishali M Ambegaonkar, Martin Horack

Int J Cardiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis